Sponsored by Precision ADVANCE, this Endpoints webinar will convene leading advanced therapy experts to discuss the future of CGTx clinical development. This discussion will be moderated by Teresa Pokladowski: Regional VP, Clinical Business Solutions (Precision for Medicine), and include insights from Kinnari Patel: President & COO (Rocket Pharmaceuticals), Suma Krishnan: Founder & President (Kystal Biotech), Dawn Buchanan: VP Clinical Operations (AffyImmune), and Ramona Repaczki-Jones: Executive Director, Commercial Treatment Center Operations, Cell Therapy (lovance Biotherapeutics, Inc).

Key points to be discussed:
  • Improving efficiency and quality of clinical research (technology, modeling, simulation)
  • Patient access and clinical trial diversity
  • Identifying and overcoming key challenges for a successful study execution
  • Key considerations for evaluating partners (CROs, vendors, etc.)